Megalabs
PrivateLast Round
Seed
Jun 27, 2024
Est. Valuation
$100M
Total Funding Raised
$90M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Megalabs operates in Healthcare & Life Sciences and is based in Canelones. Its latest recorded funding round was a Seed round in June 2024.
Megalabs is a pharmaceutical company that develops, manufactures, and commercializes therapeutic solutions, primarily serving the Latin American market.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Fashion & Beauty, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Megalabs Comparables
Compare Megalabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Grupo Bagó | 86% | |
| Laboratorios Roemmers | 83% | |
| Laboratorios Senosiain | 82% |
For institutional investors. Book with your work email.
Megalabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 27, 2024 | ||||
| Debt | Feb 3, 2023 | ||||
| Buyout/LBO | Apr 24, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Megalabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDB Invest | Debt |
| Dragonfly Capital | Seed |
| Robot Ventures | Seed |
| Big Brain Holdings | Seed |
| Folius Ventures | Seed |
| Tangent Ventures | Seed |
| Credibly Neutral | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 41% MoM, reaching 57K.
- Jul 13, 2026
Open roles increased to 292, 18% of headcount.
For institutional investors. Book with your work email.
Megalabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Megalabs's valuation, stock price, and market status.
Is Megalabs a public or private company?
Megalabs is a private company.
What is the current stock price of Megalabs?
Megalabs is a private company, so its shares have no public market price. Caplight tracks Megalabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Megalabs worth (valuation)?
Megalabs's valuation is estimated at $100.0M based on funding round data.
Can I buy Megalabs stock?
Megalabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Megalabs's last funding round?
Megalabs's most recent funding round was Seed on June 27, 2024.
Who are the main investors in Megalabs?
Key investors in Megalabs include IDB Invest, Dragonfly Capital, Santo Holding AG.
Will Megalabs IPO soon?
No public IPO plans have been announced for Megalabs.
How can I track Megalabs secondary market activity?
Caplight tracks bids, offers, and trades in Megalabs's shares on secondary markets.